Sort
82,697 grants matching “vaccine development”
Ex Vivo Female Reproductive Tract Integration In a 3D Microphysiologic System
$1,542,237Teresa K Woodruff · Northwestern University At Chicago · UH3 · FY2015 · TR
Randomized study of low versus moderate dose busulfan in transplant for severe combined immunodeficiency
$1,542,032Michael A Pulsipher · Children'S Hospital Of Los Angeles · U01 · FY2019 · AI
National Resource for Automated Molecular Microscopy
$1,542,025Bridget Olivia Carragher · Scripps Research Institute, The · P41 · FY2012 · GM
Project 1. Optimization and in vivo evaluation of HIV-1 Env trimer sortase A-conjugated nanoparticles
$1,541,147Kevin O Saunders · Duke University · U19 · FY2025 · AI
Administrative Core
$1,541,147Kevin O Saunders · Duke University · U19 · FY2025 · AI
Project 2. cGMP manufacture of HIV-1 Env trimer sortase A-conjugated nanoparticles
$1,541,146Jason Dickens · Duke University · U19 · FY2025 · AI
NIAID/MRMC Comprehensive HIV/AIDS Therapeutic and Non-Vaccine Prev Clin, Research
$1,540,906National Institute Of Allergy And Infectious Diseases · Y01 · FY2011 · AI
Area A: Development of genetically tractable, driver gene-syngeneic brain tumor models for pre-clinical adoptive TCR-T therapy
$1,540,837Qijing Li · Duke University · R33 · FY2017 · CA
Potent Boosting of Tfh1 Cells to Enhance HIV-1 Vaccine Efficacy
$1,540,805Pyone Aye · Tulane University Of Louisiana · N01 · FY2024 · AI
Defining Factors Controlling HIV Rebound
$1,540,000Jerome A. Zack · University Of California Los Angeles · P01 · FY2017 · AI
Natural History of HPV Infection to Neoplasia
$1,539,852Anna-Barbara None Moscicki · University Of California, San Francisco · R37 · FY2006 · CA
Clonal analysis of in vivo hematopoiesis
$1,539,113Cynthia E Dunbar · National Heart, Lung, And Blood Institute · ZIA · FY2020 · HL
VACCINE AND TREATMENT EVALUATION UNITS (VTEU): PROTOCOL DEVELOPMENT AND IMPLEMENTATION FOR A PHASE II THERAPEUTIC TRIAL FOR TRICHURIS TRICHIURA.
$1,539,073Patricia Winokur · University Of Iowa · N01 · FY2019 · AI
NOVEL IMMUNE BASED THERAPIES FOR MULTIPLE MYELOMA
$1,538,491Dana-Farber Cancer Institute · P01 · FY2002 · CA
HRS Yrs 29-34: Covid Antibody Revision
$1,538,248David R. Weir · University Of Michigan At Ann Arbor · U01 · FY2021 · AG
Virus biology scientific research support component
$1,537,704Beatrice H Hahn · Duke University · UM1 · FY2016 · AI
Task V32: Manufacture of Influenza Virus Human Challenge Material for Phase I/II Clinical Testing
$1,537,665Suneel Singh · Idt Biologika Gmbh · N01 · FY2024 · AI
Investigating the Human Immune Response to Ixodes scapularis Tick Bites
$1,537,444Adriana R Marques · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Novel nanovaccines against opioid use disorders
$1,537,430Chenming M Zhang · Virginia Polytechnic Inst And St Univ · UG3 · FY2019 · DA
Plant-Made Microbicides and Mucosal Vaccines for STIs
$1,537,352Arizona State University-Tempe Campus · U19 · FY2004 · AI
Cellular Vaccines for Cancer Therapy
$1,536,897University Of Michigan At Ann Arbor · P01 · FY2005 · CA
CTL and HIV Polymorphisms in Heterosexual Transmission
$1,536,864Eric Hunter · Emory University · R01 · FY2010 · AI
Vector-Borne Diseases: Biology Of Vector Host Relationship
$1,536,766Jose M Ribeiro · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Coordinating Research on Emerging Arboviral Threats Encoing the Neotropics (CREATE-NEO)
$1,536,375Nikos Vasilakis · University Of Texas Med Br Galveston · U01 · FY2022 · AI
Comprehensive SDSU/UCSD Cancer Center Partnership 1 of 2
$1,535,612Elizabeth A Klonoff · San Diego State University · U54 · FY2009 · CA